C7FX - Overview: C7 Complement, Functional, Serum
Diagnosis of C7 deficiency Investigation of a patient with an undetectable total complement level
CD138 - Overview: CD138 (Syndecan) Immunostain, Technical Component Only
Marker of plasma cells and squamous epithelial cells
Identification of herpes simplex virus I and II infection
Determining overexpression of HER2 protein of gastric and esophageal adenocarcinoma in formalin-fixed, paraffin-embedded tissue sections (no reflex to FISH testing)
HMNA - Overview: Heavy Metals, Nails
Detection of nonacute arsenic, mercury, and lead exposure
IMIPR - Overview: Imipramine and Desipramine, Serum
Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance
GLUCG - Overview: Glucagon Immunostain, Technical Component Only
Aiding in the study of islet-cell tumors and some endocrine tumors of the gastrointestinal tract
FOXP1 - Overview: FOXP1 Immunostain, Technical Component Only
Classification of lymphomas
KRT19 - Overview: Keratin 19 (KRT19) Immunostain, Technical Component Only
Aids in the identification of cells expressing low molecular weight cytokeratin (KRT19)
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.